|
Author Question: Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura can present with similar initial ... (Read 41 times) |
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.
Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.
Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%
Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.